Search Results 181-190 of 16320 for Chronic Lymphocytic Leukemia

  1. Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

    ... acute lymphoblastic leukemia that has returned after a period of improvement (relapsed). Monoclonal antibodies, such as blinatumomab, may interfere with the ...

  2. Mayo Clinic Q and A: Treatment-free remission for chronic myeloid leukemia

    DEAR MAYO CLINIC: My 32-year-old daughter was recently diagnosed with chronic myeloid leukemia. ... Chronic myelogenous leukemia ... 3 facts about acute lymphocytic ...

  3. Clinical trials - Oncology (Medical)

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  4. Publications - Fiona E. Craig, M.D. - Mayo Clinic

    Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack ...

  5. Publications - Michael B. Colgan, M.D. - Mayo Clinic

    Atypical fibroxanthoma in the setting of chronic lymphocytic leukemia and other non-Hodgkin lymphomas. Dermatol Surg. 2011 May; 37(5):671-6. Epub 2011 Mar ...

  6. Grzegorz S. Nowakowski, M.D. - Mayo Clinic Faculty Profiles

    Nowakowski is focused on the identification of novel prognostic markers in chronic lymphocytic leukemia using phage display peptide libraries. Dr ...

  7. Risk-Based Classification System of Patients with Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

    Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.

  8. Paul J. Hampel, M.D. - Doctors and Medical Staff - Mayo Clinic

    Interests · Chronic lymphocytic leukemia · Non-Hodgkin lymphoma · Hodgkin lymphoma · Hairy cell leukemia · T-cell prolymphocytic leukemia · Chimeric antigen receptor ...

  9. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  10. Cancer Treatment! Clinical Trials

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...